• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    7/10/24 1:18:59 PM ET
    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Building Materials
    Industrials
    Electrical Products
    Industrials
    Get the next $AEHL alert in real time by email

    Shares of SeaStar Medical Holding Corporation (NASDAQ:ICU) fell sharply during Wednesday's session after the company entered into a $10 million registered direct offering of 947,868 shares at $10.55 per share.

    SeaStar Medical shares dipped 34% to $8.55 on Wednesday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares jumped 139% to $2.78 after the company announced results for a Swine Model pilot study for Probudur.
    • Kazia Therapeutics Limited (NASDAQ:KZIA) gained 129% to $0.4325 after the company announced results from GBM-AGILE, a phase II/III study that included an evaluation of paxalisib versus standard of care for patients with glioblastoma.
    • Longeveron Inc. (NASDAQ:LGVN) surged 81.8% to $5.21 after the company announced that the FDA granted Regenerative Medicine Advanced Therapy designation to Lomecel-B for the treatment of mild Alzheimer’s Disease.
    • VivoPower International PLC (NASDAQ:VVPR) shares climbed 56.8% to $4.00 after the company announced it secured an extension for a $34 million loan financing facility agreement.
    • Ampco-Pittsburgh Corporation (NYSE:AP) rose 41.2% to $1.08.
    • NaaS Technology Inc. (NASDAQ:NAAS) gained 34.3% to $4.3650 after surging 68% on Tuesday.
    • Phoenix New Media Limited (NYSE:FENG) climbed 33% to $3.58.
    • Solaris Oilfield Infrastructure, Inc. (NYSE:SOI) climbed 29% to $10.67. Solaris Oilfield Infrastructure agreed to acquire Mobile Energy Rentals LLC for $200 million.
    • Lantheus Holdings, Inc. (NASDAQ:LNTH) gained 28.6% to $99.97. Lantheus recently appointed Jamie Spaeth as Chief People Officer.
    • Antelope Enterprise Holdings Limited (NASDAQ:AEHL) gained 27% to $4.60.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) rose 25% to $0.4750.
    • uniQure N.V. (NASDAQ:QURE) rose 22.6% to $8.19.
    • Aehr Test Systems (NASDAQ:AEHR) gained 21.4% to $15.05 after the company provided preliminary fourth-quarter and FY24 financial results.
    • Quhuo Limited (NASDAQ:QH) gained 21.1% to $0.5208.
    • Rocky Mountain Chocolate Factory, Inc. (NASDAQ:RMCF) climbed 18.1% to $2.08. Rocky Mountain Chocolate Factory is expected to report first-quarter results on Monday, July 15.
    • SMART Global Holdings, Inc. (NASDAQ:SGH) gained 17.4% to $27.27 after the company reported better-than-expected third-quarter financial results.
    • Hawaiian Electric Industries, Inc. (NYSE:HE) jumped 15.8% to $9.94.
    • Nisun International Enterprise Development Group Co., Ltd (NASDAQ:NISN) gained 15.8% to $7.00.
    • Gatos Silver, Inc. (NYSE:GATO) gained 15.3% to $12.86 after the company reported second-quarter Production results with record mill throughput and zinc production.
    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares rose 14.4% to $0.7743 after gaining 36% on Tuesday.
    • Endeavour Silver Corp. (NYSE:EXK) gained 10.2% to $4.3801. HC Wainwright & Co. analyst Heiko Ihle reiterated Endeavour Silver with a Buy and maintained a $6.25 price target.
    • MarineMax, Inc. (NYSE:HZO) rose 9.3% to $33.18 after Island Capital issued an open letter to shareholders and made an open proposal to acquire up to 100% interest in the YMRS business from MarineMax.
    • Soligenix, Inc. (NASDAQ:SNGX) shares rose 7.4% to $7.97. Soligenix shares jumped 271% on Tuesday after the company announced interim results for extended HyBryte treatment in early-stage CTCL patients.
    • CarMax, Inc. (NYSE:KMX) gained 5.2% to $76.03.

    Losers

    • Shineco, Inc. (NASDAQ:SISI) shares fell 40.1% to $2.70. Shineco's subsidiary Fuzhou Meida signed distribution agreements for water-soluble phospholipid concentrate beverage.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) fell 38.2% to $11.10 after jumping 94% on Tuesday.
    • Stardust Power Inc. (NASDAQ:SDST) fell 31.5% to $7.11 after gaining around 9% on Tuesday.
    • LegalZoom.com, Inc. (NASDAQ:LZ) shares fell 25.7% to $5.84 after the company announced a CEO transition and lowered its full year guidance.
    • Alarum Technologies Ltd. (NASDAQ:ALAR) declined 25% to $33.45 after the company announced estimated guidance for the first half of 2024.
    • Top KingWin Ltd (NASDAQ:TCJH) shares dipped 22.7% to $0.28.
    • Cetus Capital Acquisition Corp. (NASDAQ:CETU) fell 21.5% to $6.04.
    • VSee Health, Inc. (NASDAQ:VSEE) fell 19.2% to $5.64.
    • Dolphin Entertainment, Inc. (NASDAQ:DLPN) fell 18.4% to $0.6530.
    • Assure Holdings Corp. (NASDAQ:IONM) fell 17.2% to $4.21.
    • Annovis Bio, Inc. (NASDAQ:ANVS) declined 16.6% to $12.14.
    • RxSight, Inc. (NASDAQ:RXST) fell 16.6% to $47.52. Stifel analyst Thomas Stephan maintained RxSight with a Buy and lowered the price target from $75 to $70.
    • 10x Genomics, Inc. (NASDAQ:TXG) shares declined 14.2% to $15.65. On Tuesday, Goldman Sachs analyst Matthew Sykes maintained 10x Genomics with a Sell and lowered the price target from $26 to $16.
    • LogicMark, Inc. (NASDAQ:LGMK) shares declined 12.2% to $0.5875 after gaining around 22% on Tuesday.
    • Ziff Davis, Inc. (NASDAQ:ZD) fell 11.6% to $45.83.
    • Kura Sushi USA, Inc. (NASDAQ:KRUS) fell 10.6% to $52.29 after the company posted downbeat results for its third quarter on Tuesday.
    • Hudson Pacific Properties, Inc. (NYSE:HPP) declined 10.4% to $4.6150. Morgan Stanley analyst Ronald Kamdem downgraded Hudson Pacific Properties from Equal-Weight to Underweight and lowered the price target from $6 to $4.25.
    • BitFuFu Inc. (NASDAQ:FUFU) fell 9.7% to $4.6817.
    • ZoomInfo Technologies Inc. (NASDAQ:ZI) fell 6.6% to $11.65.
    • TransMedics Group, Inc. (NASDAQ:TMDX) declined 6.1% to $138.81.
    • IDEAYA Biosciences, Inc. (NASDAQ:IDYA) fell 5.4% to $36.59. IDEAYA priced $263 million public offering of 228,572 common shares and pre-funded warrants at $35 per share.

    Now Read This: Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $AEHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEHL
    $AEHR
    $ALAR
    $ANVS

    CompanyDatePrice TargetRatingAnalyst
    uniQure N.V.
    $QURE
    3/11/2026$35.00Neutral → Outperform
    Mizuho
    uniQure N.V.
    $QURE
    3/9/2026$60.00Equal Weight → Overweight
    Wells Fargo
    uniQure N.V.
    $QURE
    3/9/2026$35.00Sector Perform → Outperform
    RBC Capital Mkts
    Kura Sushi USA Inc.
    $KRUS
    3/6/2026$90.00Buy
    DA Davidson
    LegalZoom.com Inc.
    $LZ
    3/4/2026$6.00Equal Weight → Underweight
    Barclays
    uniQure N.V.
    $QURE
    3/3/2026$15.00Overweight → Equal Weight
    Wells Fargo
    uniQure N.V.
    $QURE
    3/3/2026$12.00Outperform → Neutral
    Mizuho
    uniQure N.V.
    $QURE
    3/2/2026$11.00Outperform → Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by O'Dowd William Iv

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/23/26 5:26:18 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    SEC Form 3 filed by new insider Weiss Omer

    3 - Alarum Technologies Ltd. (0001725332) (Issuer)

    3/19/26 4:01:19 PM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Halfon Yehuda

    3 - Alarum Technologies Ltd. (0001725332) (Issuer)

    3/19/26 4:01:21 PM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    uniQure upgraded by Mizuho with a new price target

    Mizuho upgraded uniQure from Neutral to Outperform and set a new price target of $35.00

    3/11/26 8:30:07 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    uniQure upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded uniQure from Sector Perform to Outperform and set a new price target of $35.00

    3/9/26 8:45:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    uniQure upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded uniQure from Equal Weight to Overweight and set a new price target of $60.00

    3/9/26 8:45:00 AM ET
    $QURE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HyBryte™ Treatment Results to be Presented at US Cutaneous Lymphoma Consortium Annual Workshop 2026

    Highlighting Positive Results in Comparison to Valchlor® and in Real-World Use PRINCETON, N.J., March 23, 2026 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that findings from recent supportive trials with HyBryte™ (synthetic hypericin) in the treatment of cutaneous T-cell lymphoma (CTCL) are being presented at the United States Cutaneous Lymphoma Consortium (USCLC) Workshop (March 26, 2026), which precedes the American Academy of Dermatology (AAD) Annual Meeting. Ellen Kim, MD, Director, Penn Cutane

    3/23/26 7:30:00 AM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial

    SOUTH SAN FRANCISCO, Calif., March 22, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations events and provided updated guidance related to the timing of its upcoming topline data release from the Phase 2/3 OptimUM-02 trial in first-line HLA-A2*-negative metastatic uveal melanoma. Darovasertib Phase 2/3 OptimUM-02 Trial Topline Results Investor and Analyst Webcast:Updated Topline Results Guidance: The databa

    3/22/26 10:00:00 AM ET
    $IDYA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BitFuFu Announces Unaudited 2025 Full-Year Financial Results

    SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the full year ended December 31, 2025. Full Year 2025 Financial Highlights Total revenue was $475.8 million in 2025, representing an increase of 2.7% from $463.3 million in 2024. The year-over-year increase was driven by higher revenue from Cloud Mining Solutions, Mining Equipment Sales, and Other, partially offset by a decline in revenue from Self-Mining Operations.   For the Year Ended December 31,   2025 2024Business Segment ($ in millions) Revenue % ofRevenue Revenue % of

    3/20/26 6:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer O'Dowd William Iv bought $4,929 worth of shares (3,100 units at $1.59), increasing direct ownership by 0.69% to 450,090 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/16/26 7:33:14 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,843 worth of shares (2,900 units at $1.67), increasing direct ownership by 0.65% to 446,990 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/9/26 4:53:29 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    Chief Executive Officer O'Dowd William Iv bought $4,991 worth of shares (3,100 units at $1.61), increasing direct ownership by 0.70% to 444,090 units (SEC Form 4)

    4 - Dolphin Entertainment, Inc. (0001282224) (Issuer)

    3/2/26 8:15:33 PM ET
    $DLPN
    Other Consumer Services
    Consumer Discretionary

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    SEC Filings

    View All

    SEC Form 144 filed by Stardust Power Inc.

    144 - Stardust Power Inc. (0001831979) (Subject)

    3/20/26 5:54:23 PM ET
    $SDST
    Major Chemicals
    Industrials

    SEC Form DEFA14A filed by Lantheus Holdings Inc.

    DEFA14A - Lantheus Holdings, Inc. (0001521036) (Filer)

    3/20/26 4:16:35 PM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form DEF 14A filed by Lantheus Holdings Inc.

    DEF 14A - Lantheus Holdings, Inc. (0001521036) (Filer)

    3/20/26 4:13:32 PM ET
    $LNTH
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Leadership Updates

    Live Leadership Updates

    View All

    Starboard Delivers Letter to CarMax

    Views Appointment of New CEO Keith Barr as Timely Opportunity to Address Fixable Execution Gaps and Unlock CarMax's Full Value Potential Has Nominated Directors to Help Support the Next Phase of Execution and Accelerate Shareholder Value Creation Believes CarMax's Structurally Superior Omnichannel Model Is Not Reflected in Current Performance Sees Clear Opportunities to Drive Improvement Through Enhanced Digital Execution, Reconditioning Efficiencies and Dynamic Pricing Urges a Substantially Expanded SG&A Reduction Program to Restore Cost Discipline and Enhance Long-Term Earnings Power Starboard Value LP (together with its affiliates, "Starboard"), a significant stockholder of Car

    3/11/26 8:00:00 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Endeavour Silver Announces Board and Management Updates

    VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. ("Endeavour" or the "Company") (NYSE:EXK, TSX:EDR) announces the appointment of a new member to the Board of Directors and key changes to its senior management team as the Company enters a new phase of growth and execution. Endeavour currently operates three underground mines in Mexico and Peru, supported by a robust development pipeline that positions the Company to advance its long-term strategy and move closer to becoming a senior silver producer. Appointment of George Paspalas to Endeavour's Board of Directors, Effective March 1, 2026 Mr. Paspalas is an experienced mining executive with over 40

    3/2/26 6:50:00 AM ET
    $EXK
    Precious Metals
    Basic Materials

    Donerail Issues Additional Open Letter to MarineMax Shareholders

    Disappointed by Lack of Engagement with MarineMax Board Despite Highly Credible, Premium Cash Proposal and Stated Willingness to Potentially Increase Offer Urges Shareholders to Vote AGAINST CEO Brett McGill at Upcoming Annual Meeting as a Referendum on MarineMax Immediately Commencing a Comprehensive Strategic Review Commends CalSTRS for Voting AGAINST CEO Brett McGill and AGAINST All Other Company Nominees Highlights Levin Capital's Call for an Immediate Strategic Review Following Donerail's $35 Per Share Cash Proposal  LOS ANGELES, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Donerail Group ("Donerail"), one of the largest shareholders of MarineMax, Inc. (NYSE:HZO) ("MarineMax" or the "Company

    2/23/26 8:45:00 AM ET
    $HZO
    Auto & Home Supply Stores
    Consumer Discretionary

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Financials

    Live finance-specific insights

    View All

    BitFuFu Announces Unaudited 2025 Full-Year Financial Results

    SINGAPORE, March 20, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the full year ended December 31, 2025. Full Year 2025 Financial Highlights Total revenue was $475.8 million in 2025, representing an increase of 2.7% from $463.3 million in 2024. The year-over-year increase was driven by higher revenue from Cloud Mining Solutions, Mining Equipment Sales, and Other, partially offset by a decline in revenue from Self-Mining Operations.   For the Year Ended December 31,   2025 2024Business Segment ($ in millions) Revenue % ofRevenue Revenue % of

    3/20/26 6:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    CarMax Announces Fourth Quarter Conference Call

    CarMax, Inc. (NYSE:KMX) will report its financial results for the fourth quarter ended February 28, 2026 before the market opens on April 14, 2026, and it will host a conference call with investors at 9:00 a.m. ET to discuss these results. Participants on the call will include Tom Folliard, Interim Executive Chair of the Board, Keith Barr, President and CEO, Enrique Mayor-Mora, Executive Vice President, CFO and Jon Daniels, Executive Vice President, CarMax Auto Finance. The live conference call can be accessed by dialing (800) 225-9448 (or (203) 518-9708 for international access) and entering the conference ID 3171396. A live audio webcast also will be available at investors.carmax.com.

    3/19/26 5:00:00 PM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Alarum Technologies Reports Fourth Quarter and Full Year 2025 Results

    Revenues for fourth quarter and full year 2025 of $11.8 million and $40.7 million, up 60% and 28% respectively, year-over-year; the strong growth driven by accelerating AI demand Investing strongly in enhancing capabilities, while remaining profitable with FY 2025 net profit of $1.0 million and adjusted EBITDA of $4.4 million TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR) ("Alarum" or the "Company"), a global provider of web data collection solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Financial Highlights of Full Year 2025 2025 revenues of $40.7 million, up 28% ye

    3/19/26 8:00:00 AM ET
    $ALAR
    Computer Software: Prepackaged Software
    Technology

    $AEHL
    $AEHR
    $ALAR
    $ANVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    12/4/24 1:29:12 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by LogicMark Inc.

    SC 13D/A - LogicMark, Inc. (0001566826) (Subject)

    12/3/24 3:35:39 PM ET
    $LGMK
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13D/A filed by Rocky Mountain Chocolate Factory Inc.

    SC 13D/A - Rocky Mountain Chocolate Factory, Inc. (0001616262) (Subject)

    11/29/24 2:00:08 PM ET
    $RMCF
    Specialty Foods
    Consumer Staples